Frontage, a full service CRO with operations in the U.S. and China, is expanding its bioanalytical laboratories for small molecules, large molecules and biologics, including the bioanalysis of Antibody Drug Conjugates (ADCs) by mass spectroscopy and ligand binding platforms.   Frontage has completed an expansion of its Exton, PA operations with an additional 10,000 sq.-ft. of labs, allowing for the installation of 20 additional mass spectrometers, including the SCIEX TripleTOF 6600 System for ...